Medical Technology - Latvia

Latvia

The Medical Technology market market in Latvia is expected to achieve a revenue of US$287.20m in 2024.
The largest market within this market is Medical Devices, which is projected to have a market volume of US$242.30m in the same year.
Looking ahead, the revenue is anticipated to exhibit an annual growth rate (CAGR 2024-2029) of 5.92%, leading to a market volume of US$382.80m by 2029.
When compared on a global scale, the United States is forecasted to generate the highest revenue, amounting to US$210.00bn in 2024.
Latvia's medical technology market is witnessing a surge in innovative telemedicine solutions to improve healthcare accessibility in remote areas.

Key regions: United States, Germany, China, Japan, France

Market

Region

Region comparison

Currency

Analyst Opinion

The Medical Technology market in Latvia is experiencing steady growth and development.

Customer preferences: In Latvia, customers are increasingly seeking advanced medical technologies and treatments to improve healthcare outcomes. They are looking for innovative medical devices and equipment that can provide accurate diagnoses, efficient treatments, and better patient care. Customers also prefer medical technologies that are user-friendly, cost-effective, and have a positive impact on the overall healthcare system.

Trends in the market: One of the key trends in the Medical Technology market in Latvia is the adoption of digital health solutions. With the increasing use of smartphones and internet connectivity, there is a growing demand for mobile health applications and wearable devices that can monitor and track health conditions. These technologies enable patients to take control of their own health and provide healthcare professionals with real-time data for better diagnosis and treatment. Another trend in the market is the focus on personalized medicine. Medical technologies that can provide personalized treatment plans based on an individual's genetic makeup and health history are gaining popularity in Latvia. This approach allows for targeted therapies that are more effective and have fewer side effects, leading to better patient outcomes.

Local special circumstances: Latvia has a well-developed healthcare system with a strong emphasis on preventive care. The government invests in healthcare infrastructure and promotes the use of medical technologies to improve healthcare access and quality. The country also has a high level of digital literacy, which facilitates the adoption of digital health solutions.

Underlying macroeconomic factors: The growing Medical Technology market in Latvia is supported by several macroeconomic factors. The country has a stable economy and a favorable business environment, which attracts foreign investment and encourages the development and adoption of new medical technologies. Additionally, the government provides financial incentives and support for research and development in the healthcare sector. In conclusion, the Medical Technology market in Latvia is experiencing growth and development driven by customer preferences for advanced medical technologies, the adoption of digital health solutions, and the focus on personalized medicine. The country's well-developed healthcare system, high digital literacy, and supportive macroeconomic factors contribute to the growth of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.